Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
Elisabeth Müller(University of Oslo), Alexandre Corthay(Oslo University Hospital)
Cited by 127
Related Papers
Immune Cell Composition in Human Non-small Cell Lung Cancer
|Frontiers in Immunology|2019|360
Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity
|Frontiers in Immunology|2024|5